P. Kessler

J. Wiltfang, E. Vairaktaris, C. Yapijakis, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.

J. Radich, T. Gooley, E. Bryant, 1995, Blood.

Registry of Monoclonal Gammopathies (RMG) in the Czech Republic

D. Horínek, S. Ševčíková, R. Hájek, 2015 .

Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.

J. Radich, F. Appelbaum, T. Gooley, 1997, Blood.

Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance

G. Morgan, R. Hájek, B. Walker, 2016, European journal of haematology.

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

R. Hájek, J. Gumulec, Jirí Jarkovský, 2015, PloS one.

Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.

S. Ševčíková, R. Hájek, M. Penka, 2018, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[Thrombolysis of arterial retinal occlusion using urokinase].

P. Kessler, M. Kubickova, R. Mach, 1992, Ceskoslovenska oftalmologie.

ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

B. Lämmle, P. Reitsma, C. Hack, 2007, Journal of thrombosis and haemostasis : JTH.

[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].

L. Dušek, R. Hájek, J. Gumulec, 2002, Vnitrni lekarstvi.

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients

Tetsuro Ito, R. Hájek, T. Jelínek, 2018, Current medical research and opinion.

Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.

I. Springer, J. Wiltfang, E. Nkenke, 2006, Oral oncology.

Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease

J. George, B. Lämmle, K. Friedman, 2022, Research and Practice in Thrombosis and Haemostasis.

[Prevention of venous thromboembolism in orthopaedics].

P. Kessler, 2006, Vnitrni lekarstvi.

Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

R. Hájek, T. Jelínek, M. Mistrik, 2019, Blood.

Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data

S. Ševčíková, R. Hájek, T. Jelínek, 2021, European journal of haematology.

The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI)

D. Šálek, M. Trněný, R. Pytlík, 2014 .

Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.

S. Ševčíková, R. Hájek, M. Penka, 2018, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.

T. Gooley, E. Bryant, J. Radich, 1995, Blood.